David Reardon
MD
Clinical Director, Center for Neuro-Oncology
👥Biography 个人简介
David Reardon is a leading neuro-oncologist who has evaluated next-generation checkpoint inhibitors including LAG-3 and TIGIT targeting agents in glioblastoma. His research on overcoming the immunosuppressive CNS microenvironment has been foundational for brain tumor immunotherapy. He leads clinical trials exploring novel checkpoint combinations for central nervous system malignancies.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 David Reardon 的研究动态
Follow David Reardon's research updates
留下邮箱，当我们发布与 David Reardon（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment